Flowchart of study population from multicenter population-based liver cancer screening. HBsAg, hepatitis B surface antigen; HCC, hepatocellular carcinoma; AFP, α-fetoprotein; DCP, des-γ-carboxy-prothrombin; GGT, γ-glutamyl-transpeptidase; PLT, platelet; WBC, white blood cell.